首页>
外国专利>
TARGETING LTBP3 FOR NONALCOHOLIC STEATOHEPATITIS (NASH)-INDUCED LIVER FIBROSIS
TARGETING LTBP3 FOR NONALCOHOLIC STEATOHEPATITIS (NASH)-INDUCED LIVER FIBROSIS
展开▼
机译:针对非酒精性脱脂性炎(NASH)诱导的肝纤维化的靶向LTBP3
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention relates to the treatment of fatty liver disease. More specifically, embodiments of the invention provide a pharmaceutical composition comprising a pharmaceutical carrier and a compound that reduces LTBP3 activity in liver cells.
展开▼